NPLS — NP Life Sciences Health Industry Cashflow Statement
0.000.00%
Last trade - 00:00- $15.68m
- $15.63m
- $0.16m
- 43
- 10
- 17
- 12
Annual cashflow statement for NP Life Sciences Health Industry, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.109 | -0.131 | -0.066 | -0.019 | -0.003 |
| Amortisation | |||||
| Non-Cash Items | — | 0.006 | 0 | — | — |
| Unusual Items | |||||
| Changes in Working Capital | -0.006 | -0 | -0.025 | 0.113 | -0.071 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.113 | -0.124 | -0.091 | 0.094 | -0.074 |
| Capital Expenditures | -0.009 | 0 | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.009 | 0 | — | — | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.364 | 0 | — | — | 0.022 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.243 | -0.124 | -0.091 | 0.094 | -0.051 |